Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Sci Rep
2017 Oct 09;71:12818. doi: 10.1038/s41598-017-12726-4.
Show Gene links
Show Anatomy links
Rabies virus modifies host behaviour through a snake-toxin like region of its glycoprotein that inhibits neurotransmitter receptors in the CNS.
Hueffer K
,
Khatri S
,
Rideout S
,
Harris MB
,
Papke RL
,
Stokes C
,
Schulte MK
.
???displayArticle.abstract???
Rabies virus induces drastic behaviour modifications in infected hosts. The mechanisms used to achieve these changes in the host are not known. The main finding of this study is that a region in the rabies virus glycoprotein, with homologies to snake toxins, has the ability to alter behaviour in animals through inhibition of nicotinic acetylcholine receptors present in the central nervous system. This finding provides a novel aspect to virus receptor interaction and host manipulation by pathogens in general. The neurotoxin-like region of the rabies virus glycoprotein inhibited acetylcholine responses of α4β2 nicotinic receptors in vitro, as did full length ectodomain of the rabies virus glycoprotein. The same peptides significantly altered a nicotinic receptor induced behaviour in C. elegans and increased locomotor activity levels when injected into the central nervous system of mice. These results provide a mechanistic explanation for the behavioural changes in hosts infected by rabies virus.
Figure 1. Neurotoxin-like peptides of the rabies virus glycoprotein contain polymorphic and highly conserved residues (a) and differ in binding to homologue of extracellular part of nAChR (b). (a) Polymorphism of RGP residues: 2649 mature RGP sequences downloaded from Genbank were submitted to the VIPR website and the polymorphism was determined and plotted over the length of the mature RGP. Residue 183 is the most polymorphic of all residues within the ectodomain (residues 1–440 in the mature RGP) of the protein. The inset represents the neurotoxin-like peptide domain used in this study. (b) Comparison of KD values for rabies derived peptides binding to L-AChBP determined by Surface Plasmon Resonance. L-AChBP was immobilized on Biacore CM5 sensor chips and perfused with test peptides at a flow rate of 45 ul/min at 25 degrees centigrade. Average KD values for at least three independent experiments and standard deviations are shown. Bars indicated significant differences between KD values of two peptides as determined by Student’s T-test.
Figure 2. Neurotoxin-like domain of rabies virus inhibits nicotinic receptors. Functional effects of rabies glycoprotein neurotoxin-like peptides on α4β2 nAChRs (a–c). Peptides were identical in sequence with the exception of the amino acid present at position 183 (a,b) or 196 (c). Plots shown in (a,b) show inhibition of acetylcholine-induced responses following pre-exposure to peptides containing either a alanine (a) or proline (b) at position 183. Plot (c) shows the effect of a peptide containing an aspartate at position 196 (RV-R196D). The effects of full length ectodomain is shown in panels (d,e). Panel (d) shows the response of oocytes expressing α4β2 nAChRs to co-applications of 30 µM acetylcholine 30 seconds after pre-application of buffer (orange) or RGP ectodomain (blue) at 840 nM concentration. Panel (e) shows the recovery of responses to 30 µM acetylcholine 4 minutes after exposure to RGP ectodomain.
Figure 3. Rabies neurotoxin-like peptide effects on behaviour. (a) Rabies neurotoxin-like peptide inhibits the frequency of nAChR-meditated pharyngeal pumping in C. elegans. C. elegans were injected with peptide and pharyngeal pumping was measured, p < 0.001 by student-T test. (b) Rabies neurotoxin-like peptides alter the behaviour of mice. Mice injected with the peptide were observed and the number of cage transects were determined relative to control injected mice, the horizontal line at 1 represents control injected animals. *Indicate significance at p < 0.1 (*), p < 0.05 (**) or p < 0.01 (***) using two-way ANOVA test. A representative video of injected mice can be seen in supplemental movie.
Bakker,
Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants.
2005, Pubmed
Bakker,
Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants.
2005,
Pubmed
Barber,
Alpha neurotoxins.
2013,
Pubmed
Bourne,
Crystal structure of a Cbtx-AChBP complex reveals essential interactions between snake alpha-neurotoxins and nicotinic receptors.
2005,
Pubmed
Brejc,
Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.
2001,
Pubmed
Cézilly,
Host-manipulation by parasites with complex life cycles: adaptive or not?
2010,
Pubmed
Donnelly-Roberts,
Synthetic peptides of neurotoxins and rabies virus glycoprotein behave as antagonists in a functional assay for the acetylcholine receptor.
1989,
Pubmed
Dutertre,
Nicotinic acetylcholine receptor inhibitors derived from snake and snail venoms.
2017,
Pubmed
Garduño,
Presynaptic α4β2 nicotinic acetylcholine receptors increase glutamate release and serotonin neuron excitability in the dorsal raphe nucleus.
2012,
Pubmed
Hemachudha,
Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges.
2002,
Pubmed
Holmes,
Genetic constraints and the adaptive evolution of rabies virus in nature.
2002,
Pubmed
Jackson,
Diabolical effects of rabies encephalitis.
2016,
Pubmed
Jackson,
Why does the prognosis remain so poor in human rabies?
2010,
Pubmed
Joshi,
A vertical flow chamber for Xenopus oocyte electrophysiology and automated drug screening.
2004,
Pubmed
,
Xenbase
Kauffman,
Effects of galanin-like peptide (GALP) on locomotion, reproduction, and body weight in female and male mice.
2005,
Pubmed
Kumar,
Transvascular delivery of small interfering RNA to the central nervous system.
2007,
Pubmed
Kuzmin,
Molecular epidemiology of terrestrial rabies in the former Soviet Union.
2004,
Pubmed
Lawson,
Intracerebroventricular administration of HIV-1 Tat induces brain cytokine and indoleamine 2,3-dioxygenase expression: a possible mechanism for AIDS comorbid depression.
2011,
Pubmed
Lentz,
Is the acetylcholine receptor a rabies virus receptor?
1982,
Pubmed
Lentz,
Synthetic peptides corresponding to sequences of snake venom neurotoxins and rabies virus glycoprotein bind to the nicotinic acetylcholine receptor.
1987,
Pubmed
Lewis,
Modulation of aggressive behavior in mice by nicotinic receptor subtypes.
2015,
Pubmed
Lockery,
A microfluidic device for whole-animal drug screening using electrophysiological measures in the nematode C. elegans.
2012,
Pubmed
Mello,
Efficient gene transfer in C.elegans: extrachromosomal maintenance and integration of transforming sequences.
1991,
Pubmed
Moore,
An overview of parasite-induced behavioral alterations - and some lessons from bats.
2013,
Pubmed
Morimoto,
Shedding of Gs protein (a soluble form of the viral glycoprotein) by the rabies virus-infected BHK-21 cells.
1993,
Pubmed
Papke,
Working with OpusXpress: methods for high volume oocyte experiments.
2010,
Pubmed
,
Xenbase
Roche,
Crystal structure of the low-pH form of the vesicular stomatitis virus glycoprotein G.
2006,
Pubmed
Schikorski,
Quantitative ultrastructural analysis of hippocampal excitatory synapses.
1997,
Pubmed
Shahsavar,
Structural Studies of Nicotinic Acetylcholine Receptors: Using Acetylcholine-Binding Protein as a Structural Surrogate.
2016,
Pubmed
Smit,
A glia-derived acetylcholine-binding protein that modulates synaptic transmission.
2001,
Pubmed
Streicker,
Variable evolutionary routes to host establishment across repeated rabies virus host shifts among bats.
2012,
Pubmed
Thomas,
Parasitic manipulation: where are we and where should we go?
2005,
Pubmed
Weltzin,
Pharmacological characterization of the allosteric modulator desformylflustrabromine and its interaction with alpha4beta2 neuronal nicotinic acetylcholine receptor orthosteric ligands.
2010,
Pubmed
,
Xenbase
Wirblich,
Rabies virus (RV) glycoprotein expression levels are not critical for pathogenicity of RV.
2011,
Pubmed